DLB vs NPO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
DLB exhibits a dichotomy between exceptional financial health and poor growth momentum. The Piotroski F-Score of 8/9 indicates a very strong balance sheet with minimal debt (D/E 0.02) and high liquidity, yet the stock trades at a significant premium to its Graham Number ($38.84) and Intrinsic Value ($17.29). While the company maintains an elite gross margin of 87.86%, negative YoY revenue and earnings growth, coupled with bearish insider activity and a 0/100 technical trend, offset the strong fundamental health.
NPO exhibits a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect, with a current price of $291.55 trading at a massive premium to its Graham Number ($56.27) and Intrinsic Value ($13.44). While long-term price performance has been strong, recent fundamentals have deteriorated sharply, highlighted by a -196.8% YoY EPS collapse and a disastrous recent quarterly miss. The combination of a trailing P/E of 151.85, bearish insider selling, and a technical trend score of 10/100 suggests the stock is significantly overextended.
Compare Another Pair
Related Comparisons
DLB vs NPO: Head-to-Head Comparison
This page compares Dolby Laboratories, Inc. (DLB) and Enpro Inc. (NPO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.